SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-002553
Filing Date
2024-02-05
Accepted
2024-02-05 16:40:49
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 form4-02052024_090236.html 4  
1 form4-02052024_090236.xml 4 4006
  Complete submission text file 0001415889-24-002553.txt   5443
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Dreyfus Andrew (Reporting) CIK: 0001670893 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41944 | Film No.: 24596363

Mailing Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022
Business Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022 773-255-5012
Alto Neuroscience, Inc. (Issuer) CIK: 0001999480 (see all company filings)

IRS No.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)